已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

FEV1/FVC Severity Stages for Chronic Obstructive Pulmonary Disease

医学 肺病 内科学 心脏病学 疾病严重程度 重症监护医学
作者
Surya P. Bhatt,Arie Nakhmani,Spyridon Fortis,Matthew Strand,Edwin K. Silverman,Frank C. Sciurba,Sandeep Bodduluri
出处
期刊:American Journal of Respiratory and Critical Care Medicine [American Thoracic Society]
卷期号:208 (6): 676-684 被引量:7
标识
DOI:10.1164/rccm.202303-0450oc
摘要

Rationale: The diagnosis of chronic obstructive pulmonary disease (COPD) is based on a low FEV1/FVC ratio, but the severity of COPD is classified using FEV1% predicted (ppFEV1). Objectives: To test a new severity classification scheme for COPD using FEV1/FVC ratio, a more robust measure of airflow obstruction than ppFEV1. Methods: In COPDGene (Genetic Epidemiology of COPD) (N = 10,132), the severity of airflow obstruction was categorized by Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages 1–4 (ppFEV1 of ⩾80%, ⩾50–80%, ⩾30–50%, and <30%). A new severity classification (STaging of Airflow obstruction by Ratio; STAR) was tested in COPDGene—FEV1/FVC ⩾0.60 to <0.70, ⩾0.50 to <0.60, ⩾0.40 to <0.50, and <0.40, respectively, for stages 1–4—and applied to the combined Pittsburgh SCCOR and Emphysema COPD Research Registry for replication (N = 2,017). Measurements and Main Results: The agreements (weighted Bangdiwala B values) between GOLD and the new FEV1/FVC ratio severity stages were 0.89 in COPDGene and 0.88 in the Pittsburgh cohort. In COPDGene and the Pittsburgh cohort, compared with GOLD staging, STAR provided significant discrimination between the absence of airflow obstruction and stage 1 for all-cause mortality, respiratory quality of life, dyspnea, airway wall thickness, exacerbations, and lung function decline. No major differences were noted for emphysema, small airway disease, and 6-minute-walk distance. The STAR classification system identified a greater number of adults with stage 3/4 disease who would be eligible for lung transplantation and lung volume reduction procedure evaluations. Conclusions: The new STAR severity classification scheme provides discrimination for mortality that is similar to the GOLD classification but with a more uniform gradation of disease severity. STAR differentiates patients’ symptoms, disease burden, and prognosis better than the existing scheme based on ppFEV1, and is less sensitive to race/ethnicity and other demographic characteristics.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小二郎应助hyx-dentist采纳,获得10
1秒前
hhhhhhh完成签到 ,获得积分10
2秒前
5秒前
deng完成签到 ,获得积分10
7秒前
7秒前
绿色的大嘴鸟完成签到 ,获得积分10
12秒前
llnysl完成签到 ,获得积分10
13秒前
Qc完成签到 ,获得积分10
21秒前
小糖豆完成签到,获得积分10
24秒前
24秒前
25秒前
SciGPT应助Nitric_Oxide采纳,获得40
26秒前
潇洒的擎苍完成签到,获得积分10
27秒前
MOD发布了新的文献求助10
31秒前
蒲公英完成签到,获得积分10
32秒前
英勇羿发布了新的文献求助10
34秒前
慕青应助lijing采纳,获得10
34秒前
ccm应助科研通管家采纳,获得10
35秒前
丘比特应助科研通管家采纳,获得10
35秒前
35秒前
keepmoving_12完成签到 ,获得积分10
36秒前
Ava应助meizi采纳,获得10
36秒前
MOD完成签到,获得积分10
36秒前
李爱国应助淡然的跳跳糖采纳,获得10
40秒前
41秒前
43秒前
胡林完成签到 ,获得积分0
43秒前
neocc123完成签到 ,获得积分10
43秒前
善学以致用应助sadfasf采纳,获得10
46秒前
yanmengzhen完成签到 ,获得积分10
47秒前
47秒前
烟花应助中意采纳,获得10
47秒前
48秒前
meizi发布了新的文献求助10
49秒前
乐乐乐乐乐乐应助英勇羿采纳,获得10
50秒前
Samir完成签到,获得积分10
50秒前
51秒前
淡定小白菜完成签到,获得积分10
52秒前
丁点完成签到 ,获得积分10
52秒前
Wei完成签到 ,获得积分10
53秒前
高分求助中
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Chen Hansheng: China’s Last Romantic Revolutionary 500
宽禁带半导体紫外光电探测器 388
COSMETIC DERMATOLOGY & SKINCARE PRACTICE 388
Pearson Edxecel IGCSE English Language B 300
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3142459
求助须知:如何正确求助?哪些是违规求助? 2793361
关于积分的说明 7806531
捐赠科研通 2449661
什么是DOI,文献DOI怎么找? 1303364
科研通“疑难数据库(出版商)”最低求助积分说明 626861
版权声明 601309